These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8090986)

  • 1. Follow-up of tuberculosis patients undergoing standard anti-tuberculosis chemotherapy by using a polymerase chain reaction.
    Levée G; Glaziou P; Gicquel B; Chanteau S
    Res Microbiol; 1994 Jan; 145(1):5-8. PubMed ID: 8090986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):707-12. PubMed ID: 1901200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can serial qualitative polymerase chain reaction monitoring predict outcome of pulmonary tuberculosis treatment?
    Chierakul N; Chaiprasert A; Tingtoy N; Arjratanakul W; Pattanakitsakul SN
    Respirology; 2001 Dec; 6(4):305-9. PubMed ID: 11844121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Follow-up observation on relapse of smear negative pulmonary tuberculosis after short-course chemotherapy].
    Xu WG; Gao Z; Fan BD
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):74-6. PubMed ID: 12783655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis.
    Su WJ; Feng JY; Chiu YC; Huang SF; Lee YC
    Eur Respir J; 2011 Feb; 37(2):376-83. PubMed ID: 20516049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriological investigations for short-course chemotherapy under the tuberculosis programme in two districts of India.
    Paramasivan CN; Chandrasekaran V; Santha T; Sudarsanam NM; Prabhakar R
    Tuber Lung Dis; 1993 Feb; 74(1):23-7. PubMed ID: 8495016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentially Detectable Mycobacterium tuberculosis Cells in Sputum from Treatment-Naive Subjects in Haiti and Their Proportionate Increase after Initiation of Treatment.
    McAulay K; Saito K; Warrier T; Walsh KF; Mathurin LD; Royal-Mardi G; Lee MH; Ocheretina O; Pape JW; Fitzgerald DW; Nathan CF
    mBio; 2018 Nov; 9(6):. PubMed ID: 30459198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid detection of smear-negative Mycobacterium tuberculosis by PCR and sequencing for rifampin resistance with DNA extracted directly from slides.
    Patnaik M; Liegmann K; Peter JB
    J Clin Microbiol; 2001 Jan; 39(1):51-2. PubMed ID: 11136747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative versus absolute noncontagiousness of respiratory tuberculosis on treatment.
    Long R; Bochar K; Chomyc S; Talbot J; Barrie J; Kunimoto D; Tilley P
    Infect Control Hosp Epidemiol; 2003 Nov; 24(11):831-8. PubMed ID: 14649771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
    Botha FJ; Sirgel FA; Parkin DP; van de Wal BW; Donald PR; Mitchison DA
    S Afr Med J; 1996 Feb; 86(2):155-8. PubMed ID: 8619142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The results of 9-month isoniazid-rifampin therapy for pulmonary tuberculosis under program conditions in San Francisco.
    Slutkin G; Schecter GF; Hopewell PC
    Am Rev Respir Dis; 1988 Dec; 138(6):1622-4. PubMed ID: 3144221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bacteriological examination on needle biopsy specimens of cavity and tuberculoma after a short course chemotherapy in initially sputum positive pulmonary tuberculosis patients].
    Lu SH; Wang TP; Lü W; Du RH; Wang HX; Wang ZR
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Dec; 29(12):832-4. PubMed ID: 17327088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sputum-smear-negative pulmonary tuberculosis: controlled trial of 3-month and 2-month regimens of chemotherapy.
    Lancet; 1979 Jun; 1(8131):1361-3. PubMed ID: 87829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polymerase chain reaction technique in monitoring treatment of bacillary pulmonary tuberculosis].
    An S; Fan Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jul; 21(7):392-4. PubMed ID: 11326874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smear-negative, culture-positive pulmonary tuberculosis. Six-month chemotherapy with isoniazid and rifampin.
    Dutt AK; Moers D; Stead WW
    Am Rev Respir Dis; 1990 May; 141(5 Pt 1):1232-5. PubMed ID: 2111106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
    Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Second-Generation Line Probe Assay (Hain MTBDR
    Rockwood N; Wojno J; Ghebrekristos Y; Nicol MP; Meintjes G; Wilkinson RJ
    J Clin Microbiol; 2017 May; 55(5):1508-1515. PubMed ID: 28249999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.